To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veeva by 144 shares, the number of shares held decreased 0.35% compared to the previous period and now represents 0.64% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 846 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 4.01% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 39,927 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 1.79% of the total position.
      5.04KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 22,326 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 1.88% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 11,826 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 0.98% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Incyte by 486 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 1.15% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 43,557 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 3.9% of the total position.
      85Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 93 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 1.01% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Amgen by 159 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 1.36% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 7,917 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 4.91% of the total position.
      45Comment
      Report
       
       
       
       

      Most Discussed